294 related articles for article (PubMed ID: 1909303)
1. Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection.
Fuchs D; Möller AA; Reibnegger G; Werner ER; Werner-Felmayer G; Dierich MP; Wachter H
Immunol Lett; 1991 Jun; 28(3):207-11. PubMed ID: 1909303
[TBL] [Abstract][Full Text] [Related]
2. Immune activation and decreased tryptophan in patients with HIV-1 infection.
Fuchs D; Forsman A; Hagberg L; Larsson M; Norkrans G; Reibnegger G; Werner ER; Wachter H
J Interferon Res; 1990 Dec; 10(6):599-603. PubMed ID: 2128302
[TBL] [Abstract][Full Text] [Related]
3. Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms.
Fuchs D; Möller AA; Reibnegger G; Stöckle E; Werner ER; Wachter H
J Acquir Immune Defic Syndr (1988); 1990; 3(9):873-6. PubMed ID: 2166783
[TBL] [Abstract][Full Text] [Related]
4. Increase of tryptophan in serum and in cerebrospinal fluid of patients with HIV infection during zidovudine therapy.
Fuchs D; Gisslén M; Larsson M; Norkrans G; Hagberg L; Wachter H
Adv Exp Med Biol; 1996; 398():131-4. PubMed ID: 8906255
[TBL] [Abstract][Full Text] [Related]
5. Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection.
Neurauter G; Zangerle R; Widner B; Quirchmair G; Sarcletti M; Fuchs D
Adv Exp Med Biol; 2003; 527():317-23. PubMed ID: 15206745
[TBL] [Abstract][Full Text] [Related]
6. Effects of interferons beta or gamma on neopterin biosynthesis and tryptophan degradation by human alveolar macrophages in vitro: synergy with lipopolysaccharide.
Meyer KC; Cornwell R; Carlin JM; Powers C; Irizarry A; Byrne GI; Borden EC
Am J Respir Cell Mol Biol; 1992 Jun; 6(6):639-46. PubMed ID: 1591013
[TBL] [Abstract][Full Text] [Related]
7. Tryptophan degradation in patients infected by human immunodeficiency virus.
Werner ER; Fuchs D; Hausen A; Jaeger H; Reibnegger G; Werner-Felmayer G; Dierich MP; Wachter H
Biol Chem Hoppe Seyler; 1988 May; 369(5):337-40. PubMed ID: 3166737
[TBL] [Abstract][Full Text] [Related]
8. Increased neopterin production and tryptophan degradation in advanced Parkinson's disease.
Widner B; Leblhuber F; Fuchs D
J Neural Transm (Vienna); 2002 Feb; 109(2):181-9. PubMed ID: 12075858
[TBL] [Abstract][Full Text] [Related]
9. Neopterin Levels and Indoleamine 2,3-Dioxygenase Activity as Biomarkers of Immune System Activation and Childhood Allergic Diseases.
Ünüvar S; Erge D; Kılıçarslan B; Gözükara Bağ HG; Çatal F; Girgin G; Baydar T
Ann Lab Med; 2019 May; 39(3):284-290. PubMed ID: 30623620
[TBL] [Abstract][Full Text] [Related]
10. Decreased plasma tryptophan in pregnancy.
Schröcksnadel H; Baier-Bitterlich G; Dapunt O; Wachter H; Fuchs D
Obstet Gynecol; 1996 Jul; 88(1):47-50. PubMed ID: 8684760
[TBL] [Abstract][Full Text] [Related]
11. Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection.
Zangerle R; Widner B; Quirchmair G; Neurauter G; Sarcletti M; Fuchs D
Clin Immunol; 2002 Sep; 104(3):242-7. PubMed ID: 12217334
[TBL] [Abstract][Full Text] [Related]
12. The kynurenine pathway activities in a sub-Saharan HIV/AIDS population.
Bipath P; Levay PF; Viljoen M
BMC Infect Dis; 2015 Aug; 15():346. PubMed ID: 26285873
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori and serum kynurenine-tryptophan ratio in patients with colorectal cancer.
Engin AB; Karahalil B; Karakaya AE; Engin A
World J Gastroenterol; 2015 Mar; 21(12):3636-43. PubMed ID: 25834331
[TBL] [Abstract][Full Text] [Related]
14. Activated cellular immunity and decreased serum tryptophan in healthy pregnancy.
Fuchs D; Schröcksnadel H; Baier-Bitterlich G; Dapunt O; Wachter H
Adv Exp Med Biol; 1996; 398():149-53. PubMed ID: 8906258
[TBL] [Abstract][Full Text] [Related]
15. Influence of immunosuppressive agents on tryptophan degradation and neopterin production in human peripheral blood mononuclear cells.
Schroecksnadel S; Sucher R; Kurz K; Fuchs D; Brandacher G
Transpl Immunol; 2011 Sep; 25(2-3):119-23. PubMed ID: 21742032
[TBL] [Abstract][Full Text] [Related]
16. Neopterin and interferon-gamma in serum and cerebrospinal fluid of patients with HIV-associated neurologic disease.
Griffin DE; McArthur JC; Cornblath DR
Neurology; 1991 Jan; 41(1):69-74. PubMed ID: 1898675
[TBL] [Abstract][Full Text] [Related]
17. Tryptophan degradation in patients with gynecological cancer correlates with immune activation.
Schroecksnadel K; Winkler C; Fuith LC; Fuchs D
Cancer Lett; 2005 Jun; 223(2):323-9. PubMed ID: 15896467
[TBL] [Abstract][Full Text] [Related]
18. Neopterin production and tryptophan degradation in acute Lyme neuroborreliosis versus late Lyme encephalopathy.
Gasse T; Murr C; Meyersbach P; Schmutzhard E; Wachter H; Fuchs D
Eur J Clin Chem Clin Biochem; 1994 Sep; 32(9):685-9. PubMed ID: 7865624
[TBL] [Abstract][Full Text] [Related]
19. Tryptophan degradation and immune activation in Alzheimer's disease.
Widner B; Leblhuber F; Walli J; Tilz GP; Demel U; Fuchs D
J Neural Transm (Vienna); 2000; 107(3):343-53. PubMed ID: 10821443
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal study of tryptophan degradation during and after pregnancy.
Schröcksnadel K; Widner B; Bergant A; Neurauter G; Schennach H; Schröcksnadel H; Fuchs D
Life Sci; 2003 Jan; 72(7):785-93. PubMed ID: 12479977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]